The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin

eLife

Volumn 2014, Issue 3, 2014, Pages

  Thyagarajan, Bargavi ^a   Bloom, Jesse D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS DNA; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMPLICON; ANTIGENIC VARIATION; ARTICLE; CODON; CONTROLLED STUDY; EVOLUTIONARY ADAPTATION; HUMAN; HUMAN CELL; MUTATION RATE; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; POLYMERASE CHAIN REACTION; REVERSE GENETICS; SEQUENCE ANALYSIS; TISSUE CULTURE; VIRUS CULTURE; VIRUS MUTATION;

EID: 84905197658     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.03300.001     Document Type: Article

References (60)

1. Adey A, Morrison HG, Xun X, Morrison HG, Asan, Xun X, Kitzman JO, Turner EH, Stackhouse B, MacKenzie AP, Caruccio NC, Zhang X, Shendure J. 2010. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biology 11:R119. doi: 10.1186/gb-2010-11-12-r119.
2. Araya CL, Fowler DM. 2011. Deep mutational scanning: assessing protein function on a massive scale. Trends in Biotechnology 29:435-442. doi: 10.1016/j.tibtech.2011.04.003.
3. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. 2008. The influenza virus resource at the national center for biotechnology information. Journal of Virology 82:596-601. doi: 10.1128/ JVI.02005-07.
4. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A. 2014. Integrating influenza antigenic dynamics with molecular evolution. eLife 3:e01914. doi: 10.7554/eLife.01914.
5. Berkhoff E, De Wit E, Geelhoed-Mieras M, Boon A, Symons J, Fouchier R, Osterhaus A, Rimmelzwaan G. 2005. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. Journal of Virology 79:11239-11246. doi: 10.1128/JVI.79.17.11239-11246.2005.
6. Berkhoff E, de Wit E, Geelhoed-Mieras M, Boon A, Symons J, Fouchier R, Osterhaus A, Rimmelzwaan G. 2006. Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses. Vaccine 24:6594-6596. doi: 10.1016/j.vaccine.2006.05.051.
7. Berkhoff E, Geelhoed-Mieras M, Fouchier R, Osterhaus A, Rimmelzwaan G. 2007. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones. The Journal of General Virology 88:530-535. doi: 10.1099/vir.0.82120-0.
8. Bhatt S, Holmes EC, Pybus OG. 2011. The genomic rate of molecular adaptation of the human influenza a virus. Molecular Biology and Evolution 28:2443. doi: 10.1093/molbev/msr044.
9. Bloom JD. 2014. An experimentally determined evolutionary model dramatically improves phylogenetic fit. Molecular Biology and Evolution 31:1956-1978. doi: 10.1093/molbev/msu173.
10. Burton DR, Poignard P, Stanfield RL, Wilson IA. 2012. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337:183-186. doi: 10.1126/science.1225416.
11. Bustamante CD, Townsend JP, Hartl DL. 2000. Solvent accessibility and purifying selection within proteins of escherichia coli and salmonella enterica. Molecular Biology and Evolution 17:301-308. doi: 10.1093/oxfordjournals. molbev.a026310.
12. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. doi: 10.1016/0092-8674(82)90135-0.
13. Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. 2013. Defining influenza a virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host & Microbe 13:314-323. doi: 10.1016/j.chom.2013.02.008.
14. Deom CM, Caton AJ, Schulze IT. 1986. Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proceedings of the National Academy of Sciences of the United States of America 83:3771-3775. doi: 10.1073/pnas.83.11.3771.
15. Duffy S, Shackelton LA, Holmes EC. 2008. Rates of evolutionary change in viruses: patterns and determinants. Nature Reviews Genetics 9:267-276. doi: 10.1038/nrg2323.
16. Felsenstein J. 1973. Maximum likelihood and minimum-step methods for estimating evolutionary trees from data on discrete characters. Systematic Zoology 22:240-249. doi: 10.2307/2412304.
17. Felsenstein J. 1981. Evolutionary trees from DNA sequences: a maximum likelihood approach. Journal of Molecular Evolution 17:368-376. doi: 10.1007/BF01734359.
18. Firnberg E, Ostermeier M. 2012. PFunkel: efficient, expansive, user-defined mutagenesis. PLOS ONE 7:e52031. doi: 10.1371/journal.pone.0052031.
19. Fowler DM, Araya CL, Fleishman SJ, Kellogg EH, Stephany JJ, Baker D, Fields S. 2010. High-resolution mapping of protein sequence-function relationships. Nature Methods 7:741-746. doi: 10.1038/nmeth.1492.
20. Gamblin SJ, Haire LF, Russell RJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, Ha Y, Vasisht N, Steinhauer DA, Daniels RS, Elliot A, Wiley DC, Skehel JJ. 2004. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303:1838-1842. doi: 10.1126/science.1093155.
21. Gil M, Zanetti MS, Zoller S, Anisimova M. 2013. Codonphyml: fast maximum likelihood phylogeny estimation under codon substitution models. Molecular Biology and Evolution 30:1270-1280. doi: 10.1093/molbev/ mst034.
22. Goldman N, Yang Z. 1994. A codon-based model of nucleotide substitution probabilities for protein-coding DNA sequences. Molecular Biology and Evolution 11:725-736.
23. Gong LI, Bloom JD. 2014. Epistatically interacting substitutions are enriched during adaptive protein evolution. PLOS Genetics 10:e1004328. doi: 10.1371/journal.pgen.1004328.
24. Gong LI, Suchard MA, Bloom JD. 2013. Stability-mediated epistasis constrains the evolution of an influenza protein. eLife 2:e00631. doi: 10.7554/eLife.00631.
25. Goto H, Kawaoka Y. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proceedings of the National Academy of Sciences of the United States of America 95:10224-10228. doi: 10.1073/pnas.95.17.10224.
26. Halpern AL, Bruno WJ. 1998. Evolutionary distances for protein-coding sequences: modeling site-specific residue frequencies. Molecular Biology and Evolution 15:910-917. doi: 10.1093/oxfordjournals.molbev.a025995.
27. Heaton NS, Sachs D, Chen CJ, Hai R, Palese P. 2013. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and ns1 proteins. Proceedings of the National Academy of Sciences of the United States of America 110:20248-20253. doi: 10.1073/pnas.1320524110.
28. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proceedings of the National Academy of Sciences of the United States of America 97:6108-6113. doi: 10.1073/pnas.100133697.
29. Jain PC, Varadarajan R. 2014. A rapid, efficient, and economical inverse polymerase chain reaction-based method for generating a site saturation mutant library. Analytical Biochemistry 449:90-98. doi: 10.1016/j. ab.2013.12.002.
30. Joosten RP, Te Beek TA, Krieger E, Hekkelman ML, Hooft RW, Schneider R, Sander C, Vriend G. 2011. A series of PDB related databases for everyday needs. Nucleic Acids Research 39:D411-D419. doi: 10.1093/nar/gkq1105.
31. Koel BF, Burke DF, Bestebroer TM, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ. 2013. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342:976-979. doi: 10.1126/science.1244730.
32. Koelle K, Cobey S, Grenfell B, Pascual M. 2006. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:1898-1903. doi: 10.1126/science.1132745.
33. Kosiol C, Holmes I, Goldman N. 2007. An empirical codon model for protein sequence evolution. Molecular Biology and Evolution 24:1464-1479. doi: 10.1093/molbev/msm064.
34. Lipsitch M, O'Hagan JJ. 2007. Patterns of antigenic diversity and the mechanisms that maintain them. Journal of the Royal Society Interface 4:787-802. doi: 10.1098/rsif.2007.0229.
35. Łuksza M, Lässig M. 2014. A predictive fitness model for influenza. Nature 507:57-61. doi: 10.1038/nature13087.
36. Marsh GA, Hatami R, Palese P. 2007. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. Journal of Virology 81:9727-9736. doi: 10.1128/ JVI.01144-07.
37. Marsh GA, Rabadán R, Levine AJ, Palese P. 2008. Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. Journal of Virology 82:2295-2304. doi: 10.1128/ JVI.02267-07.
38. Martin J, Wharton SA, Lin YP, Takemoto DK, Skehel JJ, Wiley DC, Steinhauer DA. 1998. Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology 241:101-111. doi: 10.1006/ viro.1997.8958.
39. Nakajima S, Brown DJ, Ueda M, Nakajima K, Sugiura A, Pattnaik AK, Nayak DP. 1986. Identification of the defects in the hemagglutinin gene of two temperature-sensitive mutants of A/WSN/33 influenza virus. Virology 154:279-285. doi: 10.1016/0042-6822(86)90454-X.
40. Pond SK, Delport W, Muse SV, Scheffler K. 2010. Correcting the bias of empirical frequency parameter estimators in codon models. PLOS ONE 5:e11230. doi: 10.1371/journal.pone.0011230.
41. Pond SL, Frost SD, Muse SV. 2005. Hyphy: hypothesis testing using phylogenies. Bioinformatics 21:676-679. doi: 10.1093/bioinformatics/bti079.
42. Posada D, Buckley TR. 2004. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Systematic Biology 53:793-808. doi: 10.1080/10635150490522304.
43. Povolotskaya IS, Kondrashov FA. 2010. Sequence space and the ongoing expansion of the protein universe. Nature 465:922-926. doi: 10.1038/nature09105.
44. Qiao H, Armstrong RT, Melikyan GB, Cohen FS, White JM. 1999. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Molecular Biology of the Cell 10:2759-2769. doi: 10.1091/mbc.10.8.2759.
45. Ramsey DC, Scherrer MP, Zhou T, Wilke CO. 2011. The relationship between relative solvent accessibility and evolutionary rate in protein evolution. Genetics 188:479-488. doi: 10.1534/genetics.111.128025.
46. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 27:493-497.
47. Rimmelzwaan G, Berkhoff E, Nieuwkoop N, Fouchier R, Osterhaus A. 2004. Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations. Journal of Virology 78:8946-8949. doi: 10.1128/JVI.78.16.8946-8949.2004.
48. Russell R, Gamblin S, Haire L, Stevens D, Xiao B, Ha Y, Skehel J. 2004. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287-296. doi: 10.1016/j. virol.2004.04.040.
49. Sheshberadaran H, Chen SN, Norrby E. 1983. Monoclonal antibodies against five structural components of measles virus i. characterization of antigenic determinants on nine strains of measles virus. Virology 128:341-353. doi: 10.1016/0042-6822(83)90261-1.
50. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. doi: 10.1126/ science.1097211.
51. Stech J, Garn H, Wegmann M, Wagner R, Klenk H. 2005. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nature Medicine 11:683-689. doi: 10.1038/nm1256.
52. Tien M, Meyer AG, Spielman SJ, Wilke CO. 2013. Maximum allowed solvent accessibilites of residues in proteins. PLOS ONE 8:e80635. doi: 10.1371/journal.pone.0080635.
53. Valkenburg SA, Quiñones-Parra S, Gras S, Komadina N, McVernon J, Wang Z, Halim H, Iannello P, Cole C, Laurie K, Kelso A, Rossjohn J, Doherty PC, Turner SJ, Kedzierska K. 2013. Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides. Nature Communications 4:2663. doi: 10.1038/ ncomms3663.
54. Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K. 2011. Immunity to seasonal and pandemic influenza A viruses. Microbes and Infection 13:489-501. doi: 10.1016/j.micinf.2011.01.007.
55. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao HX, Harrison SC. 2011. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proceedings of the National Academy of Sciences of the United States of America 108:14216-14221. doi: 10.1073/pnas.1111497108.
56. Wiley D, Wilson I, Skehel J. 1981. Structural identification of the antibody-binding sites of hong kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. doi: 10.1038/289373a0.
57. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry 56:365-394. doi: 10.1146/annurev.bi.56.070187.002053.
58. Wu NC, Young AP, Al-Mawsawi LQ, Olson CA, Feng J, Qi H, Chen SH, Lu IH, Lin CY, Chin RG, Luan HH, Nguyen N, Nelson SF, Li X, Wu TT, Sun R. 2014. High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution. Scientific Reports 4:4942. doi: 10.1038/srep04942.
59. Yang Z, Nielsen R, Goldman N, Pedersen AMK. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
60. Yewdell J, Webster R, Gerhard W. 1979. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 279:246-248. doi: 10.1038/279246a0.